FasterCures brought together speakers to discuss the opportunities and challenges of long-term follow-up data collection for cell and gene therapy.
The human and economic toll of COVID-19 has shocked the world into an awareness of the dangers and implications of zoonotic diseases — defined as diseases that transfer from animals to humans, sometimes with devastating consequences.
The COVID-19 pandemic highlighted numerous shortcomings in the average public healthcare system. The lack of affordable and accessible primary care facilities and trained medical staff, alongside infrastructure disparities between rural areas and cities, have funneled patients to hospitals and placed large strains on their medical resources and human capital.
The United States and Israel recently agreed to expand collaboration between USAID and MASHAV, Israel's Development Agency of International Cooperation, through co-innovation and the deployment of technology solutions to bolster and foster self-reliance in emerging and frontier markets. Chief among their priorities are the digital deployment and the dissemination of 5G technology and the promotion of policies and pro
How are nonprofit organizations leveraging venture philanthropy to accelerate the development of treatments and cures? As part of The Research Acceleration and Innovation Network (TRAIN) webinar series, FasterCures takes a deeper dive into the venture philanthropy approach of EB Research Partnership, the largest global nonprofit organization dedicated to treating and curing Epidermolysis Bullosa (EB). To date, EB Res
